Semaglutide dose Among 715 patients with no type 2 diabetes diagnosis, 353 (49%) had a high documented semaglutide dose of either 1.7 mg, 2.0 mg, or 2.4 mg, compared with only 116 (15%) of 767 patients with type 2 diabetes ( Figure 1 )
Combined Treatment Strategies Semaglutide is most effective when integrated with Auris broader wellness ecosystem
Compounded semaglutide and tirzepatide are not FDA-approved and are prepared by licensed 503A compounding pharmacies pursuant to a valid patient-specific prescription under medical supervision
Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider
48,49 The available doses of oral semaglutide are 3 mg, 7 mg, and 14 mg (Table 1)
The tirzepatide meal plan provides structured daily templates